Skip to content
PubMed This is a summary of 88 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 88 referenced papers

Top Authors

Richard Eastell
University of Sheffield
Steven R. Cummings
San Francisco General Hospital
Pauline M. Camacho
Loyola University Medical Center
Nelson B. Watts
Mercy Health
William D. Leslie
University of Manitoba
Stephanie S. Faubion
Mayo Clinic in Florida
John А. Kanis
University of Sheffield
E. Michael Lewiecki
New Mexico Clinical Research & Osteoporosis Center
Michael R. McClung
Bone Health and Osteoporosis Foundation
Catherine Sherrington
The University of Sydney

Top Institutions

Ranked by publications Top 10 institutions
07

Sichuan University

Chengdu, China

175 papers

References

References (88)
  1. 1

    The Effect of the Lumbar Vertebral Malpositioning on Bone Mineral Density Measurements of the Lumbar Spine by Dual-Energy X-Ray Absorptiometry.

    Izadyar S, Golbarg S, Takavar A, Zakariaee SS

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2016; (19(3)):277-81.

    PMID: 26778450
  2. 2

    Clinical Practice. Postmenopausal Osteoporosis.

    Black DM, Rosen CJ

    The New England journal of medicine 2016; (374(3)):254-62 doi:10.1056/NEJMcp1513724.

    PMID: 26789873
  3. 3

    Teriparatide for osteoporosis: importance of the full course.

    Lindsay R, Krege JH, Marin F, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(8)):2395-410 doi:10.1007/s00198-016-3534-6.

    PMID: 26902094
  4. 4

    Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect in Routine Clinical Practice: A Registry-Based Cohort Study.

    Leslie WD, Majumdar SR, Morin SN, Lix LM

    Annals of internal medicine 2016; (165(7)):465-472 doi:10.7326/M15-2937.

    PMID: 27428723
  5. 5

    Postmenopausal osteoporosis.

    Eastell R, O'Neill TW, Hofbauer LC, et al.

    Nature reviews. Disease primers 2016; (2()):16069 doi:10.1038/nrdp.2016.69.

    PMID: 27681935
  6. 6

    Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study.

    Kim CS, Bae EH, Ma SK, et al.

    PloS one 2016; (11(11)):e0166792 doi:10.1371/journal.pone.0166792.

    PMID: 27855207
  7. 7

    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.

    Wright NC, Saag KG, Dawson-Hughes B, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(4)):1225-1232 doi:10.1007/s00198-016-3865-3.

    PMID: 27966104
  8. 8

    Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases.

    Lewiecki EM, Bilezikian JP, Bukata SV, et al.

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2017; (20(2)):134-152 doi:10.1016/j.jocd.2017.01.001.

    PMID: 28185765
  9. 9

    Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).

    Leder BZ, Tsai JN, Jiang LA, Lee H

    Bone 2017; (98()):54-58 doi:10.1016/j.bone.2017.03.006.

    PMID: 28286299
  10. 10

    Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study.

    White VanGompel EC, Franks P, Robbins JA, Fenton JJ

    Journal of general internal medicine 2017; (32(10)):1090-1096 doi:10.1007/s11606-017-4094-y.

    PMID: 28634907
  11. 11

    Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.

    Zanchetta MB, Boailchuk J, Massari F, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(1)):41-47 doi:10.1007/s00198-017-4242-6.

    PMID: 28975362
  12. 12

    The role of diabetes mellitus and BMI in the surgical treatment of ankle fractures.

    Lanzetti RM, Lupariello D, Venditto T, et al.

    Diabetes/metabolism research and reviews 2018; (34(2)) doi:10.1002/dmrr.2954.

    PMID: 29031012
  13. 13

    Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.

    Cummings SR, Ferrari S, Eastell R, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(2)):190-198 doi:10.1002/jbmr.3337.

    PMID: 29105841
  14. 14

    Denosumab: A Review in Postmenopausal Osteoporosis.

    Deeks ED

    Drugs & aging 2018; (35(2)):163-173 doi:10.1007/s40266-018-0525-7.

    PMID: 29435849
  15. 15

    CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE QUALITY OF DXA SCANS AND REPORTS.

    Licata AA, Binkley N, Petak SM, Camacho PM

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(2)):220-229 doi:10.4158/CS-2017-0081.

    PMID: 29466058
  16. 16

    FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.

    Cosman F, Crittenden DB, Ferrari S, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(7)):1219-1226 doi:10.1002/jbmr.3427.

    PMID: 29573473
  17. 17

    Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.

    McClung MR, Brown JP, Diez-Perez A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(8)):1397-1406 doi:10.1002/jbmr.3452.

    PMID: 29694685
  18. 18

    [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]

    Lamy O, Gonzalez Rodriguez E, Stoll D, et al.

    Praxis 2018; (107(12)):649-654 doi:10.1024/1661-8157/a002997.

    PMID: 29871576
  19. 19

    Prognosis of dental implants in patients with low bone density: A systematic review and meta-analysis.

    Radi IA, Ibrahim W, Iskandar SMS, AbdelNabi N

    The Journal of prosthetic dentistry 2018; (120(5)):668-677 doi:10.1016/j.prosdent.2018.01.019.

    PMID: 30006226
  20. 20

    Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.

    Hasegawa T, Hayashida S, Kondo E, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(1)):231-239 doi:10.1007/s00198-018-4746-8.

    PMID: 30406309
  21. 21

    Treating osteoporosis to prevent fractures: current concepts and future developments.

    Lorentzon M

    Journal of internal medicine 2019; (285(4)):381-394 doi:10.1111/joim.12873.

    PMID: 30657216
  22. 22

    Stopping Denosumab.

    Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG

    Current osteoporosis reports 2019; (17(1)):8-15 doi:10.1007/s11914-019-00502-4.

    PMID: 30659428
  23. 23

    Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.

    Lyu H, Yoshida K, Tedeschi SK, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(4)):923-927 doi:10.1007/s00198-019-04847-5.

    PMID: 30680429
  24. 24

    The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey.

    Zeng Q, Li N, Wang Q, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(10)):1789-1797 doi:10.1002/jbmr.3757.

    PMID: 31067339
  25. 25

    Fracture risk following intermission of osteoporosis therapy.

    Dennison EM, Cooper C, Kanis JA, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(9)):1733-1743 doi:10.1007/s00198-019-05002-w.

    PMID: 31175404
  26. 26

    "Holidays" for osteoporosis drugs: A case-based approach.

    Anagnostis P, Paschou SA, Kenanidis E, et al.

    Case reports in women's health 2019; (23()):e00127 doi:10.1016/j.crwh.2019.e00127.

    PMID: 31431887
  27. 27

    Effects of clinical reanalysis in dual energy X-ray absorptiometry reports.

    Tuna F, Yavuz S, Demirbağ Kabayel DD, Sarıkaya A

    Turkish journal of physical medicine and rehabilitation 2017; (63(3)):201-206 doi:10.5606/tftrd.2017.595.

    PMID: 31453455
  28. 28

    New Frontiers in Osteoporosis Therapy.

    Cheng C, Wentworth K, Shoback DM

    Annual review of medicine 2020; (71()):277-288 doi:10.1146/annurev-med-052218-020620.

    PMID: 31509477
  29. 29

    Bisphosphonate drug holidays.

    Nayak S, Greenspan SL

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(12)):2525 doi:10.1007/s00198-019-05107-2.

    PMID: 31616961
  30. 30

    Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

    Kanis JA, Harvey NC, McCloskey E, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2020; (31(1)):1-12 doi:10.1007/s00198-019-05176-3.

    PMID: 31720707
  31. 31

    The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis.

    Li J, Chen X, Lu L, Yu X

    Cytokine & growth factor reviews 2020; (52()):88-98 doi:10.1016/j.cytogfr.2020.02.003.

    PMID: 32081538
  32. 32

    Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?

    Statham L, Abdy S, Aspray TJ

    Drugs in context 2020; (9()) doi:10.7573/dic.2020-1-3.

    PMID: 32426015
  33. 33

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.

    Camacho PM, Petak SM, Binkley N, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020; (26(Suppl 1)):1-46 doi:10.4158/GL-2020-0524SUPPL.

    PMID: 32427503
  34. 34

    Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases.

    Ru JY, Wang YF

    Cell death & disease 2020; (11(10)):846 doi:10.1038/s41419-020-03059-8.

    PMID: 33046704
  35. 35

    Osteoclast differentiation by RANKL and OPG signaling pathways.

    Udagawa N, Koide M, Nakamura M, et al.

    Journal of bone and mineral metabolism 2021; (39(1)):19-26 doi:10.1007/s00774-020-01162-6.

    PMID: 33079279
  36. 36

    Evidence on physical activity and osteoporosis prevention for people aged 65+ years: a systematic review to inform the WHO guidelines on physical activity and sedentary behaviour.

    Pinheiro MB, Oliveira J, Bauman A, et al.

    The international journal of behavioral nutrition and physical activity 2020; (17(1)):150 doi:10.1186/s12966-020-01040-4.

    PMID: 33239014
  37. 37

    MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS.

    Fujii T, Murata K, Mun SH, et al.

    Bone research 2021; (9(1)):4 doi:10.1038/s41413-020-00120-2.

    PMID: 33424022
  38. 38

    Glucocorticoid Receptor Regulates TNFSF11 Transcription by Binding to Glucocorticoid Responsive Element in TNFSF11 Proximal Promoter Region.

    Lovšin N, Marc J

    International journal of molecular sciences 2021; (22(3)) doi:10.3390/ijms22031054.

    PMID: 33494362
  39. 39

    DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis.

    Shevroja E, Cafarelli FP, Guglielmi G, Hans D

    Endocrine 2021; (74(1)):20-28 doi:10.1007/s12020-021-02806-x.

    PMID: 34245432
  40. 40

    Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.

    Liu J, Laster A, Xu X, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021; (36(12)):2309-2316 doi:10.1002/jbmr.4439.

    PMID: 34490946
  41. 41

    Role of nitric oxide in type 1 diabetes-induced osteoporosis.

    Jeddi S, Yousefzadeh N, Kashfi K, Ghasemi A

    Biochemical pharmacology 2022; (197()):114888 doi:10.1016/j.bcp.2021.114888.

    PMID: 34968494
  42. 42

    Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study.

    Mok CC, Tse SM, Chan KL, Ho LY

    Therapeutic advances in musculoskeletal disease 2022; (14()):1759720X221074451 doi:10.1177/1759720X221074451.

    PMID: 35154418
  43. 43

    RANKL biology.

    Takegahara N, Kim H, Choi Y

    Bone 2022; (159()):116353 doi:10.1016/j.bone.2022.116353.

    PMID: 35181574
  44. 44

    Evaluation of Quality and Bone Microstructure Alterations in Patients with Type 2 Diabetes: A Narrative Review.

    Martínez-Montoro JI, García-Fontana B, García-Fontana C, Muñoz-Torres M

    Journal of clinical medicine 2022; (11(8)) doi:10.3390/jcm11082206.

    PMID: 35456299
  45. 45

    Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.

    Sköld C, Kultima K, Freyhult E, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(9)):1-8 doi:10.1007/s00198-022-06423-w.

    PMID: 35608639
  46. 46

    The role of osteoanabolic agents in the management of patients with osteoporosis.

    McClung MR, Rothman MS, Lewiecki EM, et al.

    Postgraduate medicine 2022; (134(6)):541-551 doi:10.1080/00325481.2022.2069582.

    PMID: 35635798
  47. 47

    Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.

    Zhang F, Wang Z, Su H, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(9)):1937-1947 doi:10.1007/s00198-022-06456-1.

    PMID: 35704055
  48. 48

    Management of osteoporosis in patients with chronic kidney disease.

    Abdalbary M, Sobh M, Elnagar S, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(11)):2259-2274 doi:10.1007/s00198-022-06462-3.

    PMID: 35748896
  49. 49

    The 2022 hormone therapy position statement of The North American Menopause Society.

    Menopause (New York, N.Y.) 2022; (29(7)):767-794 doi:10.1097/GME.0000000000002028.

    PMID: 35797481
  50. 50

    Comparison of bone mineral density and Fracture Risk Assessment Tool in Saudi women with and without type 2 diabetes mellitus: A cross-sectional study.

    Alfadhli EM, Alsharif AS, Alharbi RA, et al.

    Saudi medical journal 2022; (43(7)):700-707 doi:10.15537/smj.2022.43.7.20220144.

    PMID: 35830997
  51. 51

    Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin-/- mice through increasing sclerostin and RANKL/OPG.

    Ma J, Wang A, Zhang H, et al.

    Bone 2022; (164()):116511 doi:10.1016/j.bone.2022.116511.

    PMID: 35933095
  52. 52

    Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis.

    Ebina K, Etani Y, Tsuboi H, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(11)):2441-2443 doi:10.1007/s00198-022-06545-1.

    PMID: 36066579
  53. 53

    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis.

    Yu G, Tong S, Liu J, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2023; (34(4)):641-658 doi:10.1007/s00198-022-06626-1.

    PMID: 36527476
  54. 54

    To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday.

    Khan TS, Sinha P, Rosen H

    Cleveland Clinic journal of medicine 2023; (90(3)):173-180 doi:10.3949/ccjm.90a.22071.

    PMID: 36858618
  55. 55

    Environmental interventions for preventing falls in older people living in the community.

    Clemson L, Stark S, Pighills AC, et al.

    The Cochrane database of systematic reviews 2023; (3()):CD013258 doi:10.1002/14651858.CD013258.pub2.

    PMID: 36893804
  56. 56

    Coping With 'Scanxiety': Within-Person Processes in Lung Cancer.

    Dunsmore VJ, Neupert SD

    Psychological reports 2025; (128(2)):702-722 doi:10.1177/00332941231164336.

    PMID: 36964680
  57. 57

    Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk.

    McClung MR, Betah D, Deignan C, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2023; (29(9)):716-722 doi:10.1016/j.eprac.2023.06.011.

    PMID: 37406858
  58. 58

    The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.

    Xu J, Yu L, Liu F, et al.

    Frontiers in immunology 2023; (14()):1222129 doi:10.3389/fimmu.2023.1222129.

    PMID: 37475866
  59. 59

    A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.

    Fernandes TL, Viezzer Fernandes B, Jitumori C, Franco GCN

    The American journal of case reports 2023; (24()):e941144 doi:10.12659/AJCR.941144.

    PMID: 37867315
  60. 60

    The RANK-RANKL-OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer.

    De Leon-Oliva D, Barrena-Blázquez S, Jiménez-Álvarez L, et al.

    Medicina (Kaunas, Lithuania) 2023; (59(10)) doi:10.3390/medicina59101752.

    PMID: 37893470
  61. 61

    Implementing Tai Chi Exercise in Long-Term Care to Reduce Falls.

    Miles AF, Mulkey DC

    Journal of nursing care quality 2024; (39(3)):220-225 doi:10.1097/NCQ.0000000000000756.

    PMID: 38030147
  62. 62

    Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool.

    Mazziotti G, Lania AG, Laganà M, Berruti A

    Endocrine 2024; (83(3)):594-596 doi:10.1007/s12020-023-03613-2.

    PMID: 38112923
  63. 63

    Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions.

    Zerikly R, Demetriou EW

    Women's health (London, England) 2024; (20()):17455057241231387 doi:10.1177/17455057241231387.

    PMID: 38529935
  64. 64

    Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review.

    Colón-Emeric CS, McDermott CL, Lee DS, Berry SD

    JAMA 2024; (331(16)):1397-1406 doi:10.1001/jama.2024.1416.

    PMID: 38536167
  65. 65

    Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices.

    Khan AA, Slart RHJA, Ali DS, et al.

    Mayo Clinic proceedings 2024; (99(7)):1127-1141 doi:10.1016/j.mayocp.2024.01.011.

    PMID: 38960497
  66. 66

    Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause.

    Palacios S, González SP, Sánchez-Prieto M, Fasero M

    Expert opinion on pharmacotherapy 2024; (25(10)):1359-1372 doi:10.1080/14656566.2024.2383639.

    PMID: 39039930
  67. 67

    Updated practice guideline for dual-energy X-ray absorptiometry (DXA).

    Slart RHJA, Punda M, Ali DS, et al.

    European journal of nuclear medicine and molecular imaging 2025; (52(2)):539-563 doi:10.1007/s00259-024-06912-6.

    PMID: 39316095
  68. 68

    Trabecular Bone Score to Enhance Fracture Risk Prediction and Treatment Strategies in Osteoporosis.

    Gatineau G, Hans D, Hind K

    Seminars in musculoskeletal radiology 2024; (28(5)):539-546 doi:10.1055/s-0044-1788886.

    PMID: 39406217
  69. 69

    Prevention and Management of Denosumab Discontinuation Rebound Fractures.

    Jain S

    Endocrinology and metabolism clinics of North America 2024; (53(4)):559-583 doi:10.1016/j.ecl.2024.08.002.

    PMID: 39448137
  70. 70

    Romosozumab for the treatment of osteoporosis - a systematic review.

    Mäkinen VN, Sølling AS, McClung M, Langdahl BL

    Journal of endocrinological investigation 2025; (48(3)):547-572 doi:10.1007/s40618-024-02469-1.

    PMID: 39487940
  71. 71

    Risk Factors Influencing Medication-Related Osteonecrosis of the Jaws (MRONJ) Following Dental Extraction Among Osteoporotic Patients in Taiwan.

    Wei LY, Cheng YW, Chiu WY, et al.

    Head & neck 2025; (47(4)):1151-1161 doi:10.1002/hed.28011.

    PMID: 39611589
  72. 72

    TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.

    Liu J, Zhang Y, Yu W, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2025; (36(4)):725-735 doi:10.1007/s00198-025-07423-2.

    PMID: 39994027
  73. 73

    Rate of Osteoporosis Evaluation and Treatment Following Kyphoplasty in Patients With Vertebral Compression Fractures: A Retrospective Study and Review of the Literature.

    Benedict C, Chopra AA, Pitcher M, et al.

    Geriatric orthopaedic surgery & rehabilitation 2025; (16()):21514593251332463 doi:10.1177/21514593251332463.

    PMID: 40191536
  74. 74

    A Systematic Review and Meta-Analysis to Examine the Effectiveness of Exercise Training in People With Osteoporosis or Osteopenia Compared to Other Rehabilitation Interventions on Fear of Falling and the Number of Falls.

    Johari S, MacDermid J, Graham LJ, et al.

    Journal of geriatric physical therapy (2001) 2026; (49(1)):E1-E12 doi:10.1519/JPT.0000000000000457.

    PMID: 40260904
  75. 75

    Bone microstructure and TBS in diabetes: what have we learned? A narrative review.

    Ferrari S, Akesson KE, Al-Daghri N, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2025; (36(7)):1115-1128 doi:10.1007/s00198-025-07495-0.

    PMID: 40353870
  76. 76

    Artifacts affecting dual-energy X-ray absorptiometry and bone mineral density measurements: a case report and review of the literature.

    White K, Shakir MKM, Nguyen C, Hoang TD

    Journal of medical case reports 2025; (19(1)):290 doi:10.1186/s13256-025-05353-5.

    PMID: 40544295
  77. 77

    Osteoporosis: A Review.

    Morin SN, Leslie WD, Schousboe JT

    JAMA 2025; (334(10)):894-907 doi:10.1001/jama.2025.6003.

    PMID: 40587168
  78. 78

    An underdiagnosed manifestation: Mandibular bone loss in primary hyperparathyroidism.

    Helvaci BC, Horoz M, Unver CK, et al.

    Bone 2025; (200()):117598 doi:10.1016/j.bone.2025.117598.

    PMID: 40769418
  79. 79

    Musculoskeletal manifestations of diabetes mellitus - an update.

    Ward H, Jawad AS

    Clinical medicine (London, England) 2025; (26(1)):100498 doi:10.1016/j.clinme.2025.100498.

    PMID: 40796059
  80. 80

    Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

    Hofbauer LC, Compston JE, Saag KG, et al.

    The lancet. Diabetes & endocrinology 2025; (13(11)):964-979 doi:10.1016/S2213-8587(25)00251-7.

    PMID: 41022095
  81. 81

    Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma Australia.

    Yong A, Vandyke K, Augustson B, et al.

    Expert review of hematology 2026; (19(2)):133-142 doi:10.1080/17474086.2025.2574716.

    PMID: 41082262
  82. 82

    Medication-related osteonecrosis of the jaw following osteoporosis therapy: A real-world retrospective cohort study using the TriNetX global collaborative network.

    Chen TY, Deng YL, Chen IC, et al.

    Bone 2026; (202()):117678 doi:10.1016/j.bone.2025.117678.

    PMID: 41106713
  83. 83

    Relationship between impaired glucose metabolism and bone mineral density in patients with cystic fibrosis.

    Uçar M, Turan H, Kılıç Başkan A, et al.

    European journal of pediatrics 2026; (185(2)):84.

    PMID: 41545622
  84. 84

    Exceptionally high lumbar spine DXA T-score in a nonagenarian: an artefact of degenerative spinal changes and vascular calcification.

    Peker C, Sahiner Z, Dogrul RT, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2026; (37(4)):999-1001 doi:10.1007/s00198-026-07879-w.

    PMID: 41634400
  85. 85

    Parathyroid carcinoma as an overlooked etiology of osteoporosis in postmenopausal women: a case report.

    Su J, Lei S, Jin M, et al.

    Frontiers in endocrinology 2025; (16()):1652919 doi:10.3389/fendo.2025.1652919.

    PMID: 41659338
  86. 86

    Exploring psychological distress, appraisal, and coping during the scan result journey: a qualitative study of young and middle-aged Chinese adults with advanced cancer.

    Li X, Lu Y, Fan Y, et al.

    BMC cancer 2026; (26(1)).

    PMID: 41906115
  87. 87

    Future Directions in Hypercalcemic and Normocalcemic Primary Hyperparathyroidism: FRAXplus for 10-Year Fracture Risk Assessment (A Retrospective Study).

    Gheorghe AM, Sima OC, Costachescu M, et al.

    Life (Basel, Switzerland) 2026; (16(6)) doi:10.3390/life16060932.

    PMID: 42355460
  88. 88

    Prevalence and predictors of low bone mineral density in Myasthenia gravis.

    Ducci RD, Santana LF, Kay CK, et al.

    Arquivos de neuro-psiquiatria 2026; (84(5)):1-8 doi:10.1055/s-0046-1824431.

    PMID: 42398964